Aprogen Biologics Inc. (KRX:003060)

South Korea flag South Korea · Delayed Price · Currency is KRW
700.00
+3.00 (0.43%)
At close: Jun 10, 2025, 3:30 PM KST
Market Cap 204.01B
Revenue (ttm) 68.62B
Net Income (ttm) -141.98B
Shares Out 310.99M
EPS (ttm) -895.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 623,053
Average Volume 441,210
Open 697.00
Previous Close 697.00
Day's Range 687.00 - 718.00
52-Week Range 600.00 - 2,492.00
Beta -0.04
RSI 43.04
Earnings Date Aug 13, 2025

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-vira... [Read more]

Sector Healthcare
Founded 1960
Employees 377
Stock Exchange Korea Stock Exchange
Ticker Symbol 003060
Full Company Profile

Financial Performance

In 2024, Aprogen Biologics's revenue was 67.38 billion, a decrease of -22.88% compared to the previous year's 87.36 billion. Losses were -104.98 billion, -11.24% less than in 2023.

Financial Statements

News

There is no news available yet.